Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

997117

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Crohn's Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve treatment for people with Crohn's disease.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	184958
answer	answer is ministerial correction date of answer 02/11/2018 answer text <p>The National Institute for Health and Care Excellence guidance ‘Crohn’s Disease Management in Adults, Children and Young People’, updated in 2016, sets out best practice in the diagnosis, treatment care and support of patients with the condition.</p><p> </p><p>Management options include drug therapy, dietary and lifestyle advice and, in severe or chronic active disease, surgery. The aim when treating Crohn’s disease is either to heal the inflammation and so reduce symptoms during a flare‑up ('inducing remission') or to prevent flare‑ups happening in the future ('maintaining remission'). Drug treatments can include steroids, immunosuppressants and biological medicines. For patients requiring complex surgery, NHS England specialised colorectal services nationally to support equity of access to high quality treatment for patients with Crohn’s disease.</p><p> </p><p>Since 2006, the Inflammatory bowel disease (IBD) audit programme has supported work to improving the care of people with IBD. Crohn’s and ulcerative colitis are collectively known as IBD. Evidence of improvements in care during the time of the programme included the effective demonstration that biological therapies for the treatment of IBD are safe and effective drugs as well as wider improvement to support that patients received.</p><p> </p><p>The IBD audit programme was commissioned by the Healthcare Quality Improvement Partnership, on behalf on NHS England, as part of the National Clinical Audit and Patient Outcomes Programme. The programme ended in March 2017 and its quality improvement initiatives have been transferred to the United Kingdom IBD Registry as the future vehicle for IBD audit and quality improvement.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 02/11/2018 13:21:13 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

997118

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Fibromyalgia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of people with fibromyalgia in each of the last five years.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	184959
answer	answer is ministerial correction date of answer 02/11/2018 answer text <p>This information is not collected.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 02/11/2018 13:13:49 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

997119

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cystic Hygroma
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the incidence of cystic hygroma in each of the last five years.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	184960
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>Data on the incidence and prevalence of cystic hygroma in England has only been collected since 2015 by the National Congenital Anomaly and Rare Disease Registration Service (NCARDRS) at Public Health England.</p><p> </p><p>Based on data collected by NCARDRS, the prevalence figures for cystic hygroma were approximately four per 10,000 in 2015 and four per 10,000 in 2016. Completed 2017 data will be available in February 2019.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/11/2018 15:36:17 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

997125

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will take steps to improve public awareness of the effect of the built environment on health and wellbeing.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	184966
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>Public Health England set up the Healthy Places programme in 2013 in recognition that where we live and the homes we live in have a big impact on our health and wellbeing. The programme has produced a range of publications on such impacts and developed a range of partnerships, for example with the Local Government Association and National Parks England, and programmes across national and local government which aim to raise awareness of the effect of the built environment on health and wellbeing. These publications can be seen via the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/phe-healthy-places/healthy-places" target="_blank">https://www.gov.uk/government/publications/phe-healthy-places/healthy-places</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/11/2018 15:24:12 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

997127

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Haemophilia: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, who the board members are for NHS England’s national tender for (a) factor VIII and (b) factor IX haemophilia products; which of those board members represent (i) the Northern Ireland Executive and (ii) organisations involved in Northern Ireland; and whether the board has met in Northern Ireland.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	184968
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>I refer the hon. Member to the answer I gave on 4 September 2018 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2018-07-23/167275/" target="_blank">167275</a>.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/11/2018 15:19:19 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

997128

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Haemophilia: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people who were in receipt of (a) factor VIII and (b) factor IX Extended Half Life (EHLs) products had that treatment removed for (i) clinical and (ii) non-clinical reasons in 2017-18.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	184969
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>NHS England does not collect or hold information on the number of patients who have switched from Factor VIII and Factor IX Extended Half Life products to other treatments for clinical or non-clinical reasons in 2017-18.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/11/2018 15:27:06 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

997129

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Haemophilia: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 26 June 2018 to Question 154639 on Haemophilia: Medical Treatments, if he will make a comparative assessment of treatment uptake in (a) Ireland, (b) Canada and (c) the European Union.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	184970
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>There are currently no plans for an assessment of comparative uptake compared to the uptake in Ireland, Canada and the European Union.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/11/2018 15:15:28 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

997130

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Haemophilia: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to Trigger 1 of NHS England’s Specialised Commissioning Briefing (Spring 2018), how the faster adoption of best value medicines requirement will affect the procurement of Extended Half Life factor VIII products; and which Factor VIII blood products will be covered by the Commissioning for Quality and Innovation.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	184971
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>I refer the hon. Member to the answer I gave on 4 September 2018 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2018-07-23/167279/" target="_blank">167279</a>.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/11/2018 15:28:22 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

997151

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the quality of care provision for people with diabetes in (a) NHS Coventry and Rugby Clinical Commissioning Group and (b) England.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	184864
answer	answer is ministerial correction date of answer 01/11/2018 answer text <p>There are two Clinical Commissioning Group Improvement and Assessment Framework (CCG IAF) indicators on which CCGs are given a Red, Amber or Green rating. Ratings are combined to give an overall diabetes rating for individual CCGs. The indicators are as follows:</p><p>- Diabetes patients that have achieved all the National Institute for Health and Care Excellence (NICE) recommended treatment targets: three (HbA1c, cholesterol and blood pressure) for adults and one (HbA1c) for children; and</p><p>- People with diabetes diagnosed less than a year ago who attend a structured education course.</p><p> </p><p>The overall diabetes rating for Coventry and Rugby CCG in the most recent 2016/17 assessment was ‘Requires Improvement’, following a Green rating for patients achieving all the NICE recommended treatment targets and a Red rating for attendances at structured education courses.</p><p> </p><p>CCGs across England received the following overall ratings in relation to diabetes:</p><p>- Outstanding - 40 CCGs;</p><p>- Good - 46 CCGs;</p><p>- Requires Improvement - 102 CCGs; and</p><p>- Inadequate - 19 CCGs.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 01/11/2018 17:00:53 answering member 4067 label Biography information for Steve Brine
tabling member	308 label Biography information for Mr Jim Cunningham

997153

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent discussions he has had with NHS England on the list of medical conditions that entitle people to medical exemption certificates; and whether he plans to include additional medical conditions on that list.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	184866
answer	answer is ministerial correction date of answer 01/11/2018 answer text <p>The Department has no current plans to review or amend the list of medical conditions that provide exemption from prescription charges because arrangements exist to ensure that prescriptions are affordable for everyone. Accordingly, no recent discussions about this matter have taken place at Ministerial level with NHS England.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 01/11/2018 16:57:25 answering member 4067 label Biography information for Steve Brine
tabling member	308 label Biography information for Mr Jim Cunningham